Zydus Lifesciences (ZYDUSLIFE) Share Price Hits Fresh 52-Week High of Rs 1,232
- September 29, 2026
- Posted by: Kunal Singla
- Category: News
Zydus Lifesciences Share Price is in focus after the stock touched a fresh 52-week high of Rs 1,232 and is currently trading at Rs 1,211.25. The move comes with a day change of -0.06% from the previous close of Rs 1,212, while the company carries a market capitalisation of Rs 1,19,899.96 crore. Zydus Lifesciences Share Price Today is therefore notable not because of a sharp intraday swing, but because the stock printed a new yearly high and held close to that level during the morning session.For readers tracking Zydus Lifesciences Share Price Today, the fresh high, the valuation profile and the healthcare sector context together explain why the stock is drawing attention in stock analysis and fundamental analysis screens.
Zydus Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,211.25 |
| Previous Close | Rs 1,212 |
| Today's Move | Rs -0.75 (-0.06%) |
| Open | Rs 1,219.95 |
| High | Rs 1,232 |
| Low | Rs 1,208.3 |
| Market Capitalisation | Rs 1,19,899.96 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,211.25 versus the previous close of Rs 1,212, a fall of 0.06%. The stock opened at Rs 1,219.95, reached a high of Rs 1,232 and touched a low of Rs 1,208.3.
Zydus Lifesciences Share Price Today shows a narrow move around the prior close, with the stock last traded at Rs 1,211.25 versus Rs 1,212 earlier. The session opened at Rs 1,219.95, moved to a high of Rs 1,232 and a low of Rs 1,208.3, and the fresh 52-week peak is therefore the same Rs 1,232 touched during the session. The absolute change is Rs -0.75, or -0.06%, which means Zydus Lifesciences Share Price remained close to the day’s upper range even after easing from the peak. For Zydus Lifesciences Share Price live tracking, the useful facts are simple: the yearly high was set at Rs 1,232, the current price is Rs 1,211.25 and the price action stayed within a relatively tight band. That keeps Zydus Lifesciences Share Price relevant for traders and investors who follow 52-week high stocks, while the next step is to see whether fundamentals and sector benchmarks justify the valuation.
Why Zydus Lifesciences Ltd. (ZYDUSLIFE) May Be Moving Today
Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,19,899.96 crore |
| P/E Ratio | 26.79x |
| P/B Ratio | 4.48x |
| ROE | 19.69% |
| ROCE | 21.39% |
| EPS | Rs 45.24 |
| Book Value Per Share | Rs 270.31 |
| Dividend Yield | 0.08% |
Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 26.79x, P/B 4.48x, ROE 19.69%, ROCE 21.39%. Read together, these ratios describe the company’s position rather than a recommendation.
Zydus Lifesciences Ltd. has a market capitalisation of Rs 1,19,899.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.79x, P/B at 4.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.86x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.79x |
| Benchmark Median P/E | 32.86x |
| Benchmark Average P/E | 49.14x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 4.48x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 19.69% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 21.39% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 1,19,899.96 crore |
| Benchmark Median Market Cap | Rs 782.41 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.79x, which is below the benchmark median of 32.86x, a difference of -18.47%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.7%, a difference of +68.29%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.46%, a difference of +58.92%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,08,116.47 | 99.43 | 19.28 | 18.31 | 18.2 |
| Mankind Pharma Ltd. | MANKIND | 1,02,247.25 | 49.33 | 5.99 | 12.69 | 13.24 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,00,395.34 | 31.67 | 2.67 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 98,464.42 | 26.35 | 2.51 | 9.93 | 12.76 |
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.79x compared with the displayed peer median of 33.29x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 19.69% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,19,899.96 crore. It is larger by market capitalisation than all 5 peers shown.
Why Investors Are Watching Zydus Lifesciences
- Zydus Lifesciences Share Price touched a fresh 52-week high of Rs 1,232 and is trading near that level.
- The stock is at Rs 1,211.25 after a day move of -0.06% from the previous close of Rs 1,212.
- Zydus Lifesciences Share Price has a P/E of 26.79, below the industry benchmark median of 32.86.
- ROE is 19.69% and ROCE is 21.39%, both above the same-industry benchmark medians.
- Market capitalisation stands at Rs 1,19,899.96 crore, which is well above the same-industry median.
About Zydus Lifesciences
Zydus Lifesciences Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. Zydus Lifesciences Share Price is followed in the NSE and BSE context as part of the broader Indian Stock Market universe, where company financials and valuation are often compared with peers. The business profile in this article is limited to the sector and industry classification, along with the ratios and revenue figure already noted. For readers tracking Zydus Lifesciences Stock News, the company remains a prominent name in pharmaceutical stock analysis because its market cap, return ratios and revenue base are all clearly measurable.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Zydus Lifesciences Share Price today?
Ans. Zydus Lifesciences Share Price is Rs 1,211.25, compared with the previous close of Rs 1,212. It touched a fresh 52-week high of Rs 1,232 during the session and stayed close to that level.
Why did Zydus Lifesciences Share Price hit a 52-week high?
Ans.The stock touched Rs 1,232, which is its fresh 52-week high, and then traded slightly below that mark.
What is Zydus Lifesciences market capitalisation?
Ans. Zydus Lifesciences has a market capitalisation of Rs 1,19,899.96 crore. That places Zydus Lifesciences Share Price well above the same-industry median market cap in the benchmark set and ahead of several listed peers.
What does Zydus Lifesciences valuation look like?
Ans. Zydus Lifesciences Share Price is trading at a P/E of 26.79 and a P/B of 4.48. The P/E is below the industry median, while the P/B is above the industry median.
How strong are Zydus Lifesciences profitability ratios?
Ans. Zydus Lifesciences reports ROE of 19.69% and ROCE of 21.39%. Both are above the same-industry benchmark medians, which gives Zydus Lifesciences Share Price a stronger return profile than many peers.
What are Zydus Lifesciences EPS and book value?
Ans. EPS is Rs 45.24 and book value per share is Rs 270.31. For Zydus Lifesciences Share Price, these figures help frame earnings and accounting net worth behind each share.
What is the dividend yield for Zydus Lifesciences?
Ans. Zydus Lifesciences has a dividend yield of 0.08%. That is a historical payout measure, so Zydus Lifesciences Share Price should be read alongside earnings, book value and return ratios rather than yield alone.
How does Zydus Lifesciences compare with peers?
Ans. Zydus Lifesciences Share Price has a market cap above Cipla, Laurus Labs, Mankind Pharma, Dr. Reddy's Laboratories and Aurobindo Pharma in the peer set shown, while its P/E is below several of them.
Track Zydus Lifesciences Share Price on Univest
Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Zydus Lifesciences Share Price on Univest for live price updates, 52-week levels, market cap, Fundamental Analysis and peer comparison. Zydus Lifesciences Share Price Today, valuation ratios and sector benchmarks are updated in one place for quick stock analysis.
